Literature DB >> 10958274

Use of invasive and nuclear stress testing in patients with acute ischemic coronary syndromes in a large, urban, university-affiliated hospital.

H A Dakik1, M S Verani.   

Abstract

BACKGROUND: Several recent studies have suggested a high use of invasive procedures after acute myocardial infarction, without a corresponding improvement in survival. We assessed the relative use of invasive procedures and nuclear cardiac testing during acute coronary syndromes. METHODS AND
RESULTS: We examined the in-hospital utilization rates of invasive and nuclear stress tests and their association with in-hospital mortality in all patients hospitalized with an acute coronary syndrome in a single, university-affiliated hospital for 3 years. The study cohort consisted of 1704 consecutive patients with acute myocardial infarction and 2414 patients with unstable angina pectoris. The utilization rate of nuclear stress testing was much lower than that of coronary angiography in patients with either acute myocardial infarction (11.9% vs. 73.9%, P<.001) or unstable angina (8.5% vs. 79.3%, P<.001). Patients examined with nuclear stress testing, as compared with patients examined solely by means of coronary angiography, had lower revascularization and in-hospital mortality rates, both after acute myocardial infarction (29.2% vs. 70%, P<.001, and 1.5% vs. 9.6%, P<.001, respectively) and unstable angina (14.6% vs. 80.6%, P<.001, and 1% vs. 5.1%, P<.001, respectively). Revascularization guided by means of nuclear stress testing had a lower mortality rate than that performed without the benefit of a nuclear test, both in patients with acute myocardial infarction (0% vs. 10.5%) and in patients with unstable angina (0% vs. 5.9%).
CONCLUSION: Noninvasive stress imaging was used much less often than coronary angiography in patients with acute coronary syndromes. The lower mortality rate of patients examined with nuclear stress testing, compared with patients examined solely by means of coronary angiography, deserves further study, especially in patients undergoing revascularization.

Entities:  

Mesh:

Year:  2000        PMID: 10958274     DOI: 10.1067/mnc.2000.106384

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  15 in total

1.  Determinants of the use of coronary angiography and revascularization after thrombolysis for acute myocardial infarction.

Authors:  L Pilote; D P Miller; R M Califf; J S Rao; W D Weaver; E J Topol
Journal:  N Engl J Med       Date:  1996-10-17       Impact factor: 91.245

2.  Meeting highlights: 46th Annual Scientific Sessions of the American College of Cardiology.

Authors:  J J Ferguson
Journal:  Circulation       Date:  1997-07-15       Impact factor: 29.690

3.  Guidelines for risk stratification after myocardial infarction. American College of Physicians.

Authors: 
Journal:  Ann Intern Med       Date:  1997-04-01       Impact factor: 25.391

4.  ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).

Authors:  T J Ryan; J L Anderson; E M Antman; B A Braniff; N H Brooks; R M Califf; L D Hillis; L F Hiratzka; E Rapaport; B J Riegel; R O Russell; E E Smith; W D Weaver
Journal:  J Am Coll Cardiol       Date:  1996-11-01       Impact factor: 24.094

5.  Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability.

Authors:  P R Pagley; G A Beller; D D Watson; L W Gimple; M Ragosta
Journal:  Circulation       Date:  1997-08-05       Impact factor: 29.690

6.  Coronary artery bypass grafting: the Society of Thoracic Surgeons National Database experience.

Authors:  F H Edwards; R E Clark; M Schwartz
Journal:  Ann Thorac Surg       Date:  1994-01       Impact factor: 4.330

7.  Coronary artery bypass grafting within thirty days of acute myocardial infarction. Early and late results in 406 patients.

Authors:  R Applebaum; R House; A Rademaker; A Garibaldi; Z Davis; J Guillory; A Chen; T Hoeksema
Journal:  J Thorac Cardiovasc Surg       Date:  1991-11       Impact factor: 5.209

8.  Optimal timing of coronary artery bypass graft surgery after acute myocardial infarction.

Authors:  J H Braxton; G L Hammond; G V Letsou; K L Franco; G S Kopf; J A Elefteriades; J C Baldwin
Journal:  Circulation       Date:  1995-11-01       Impact factor: 29.690

9.  Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.

Authors:  L Pilote; R M Califf; S Sapp; D P Miller; D B Mark; W D Weaver; J M Gore; P W Armstrong; E M Ohman; E J Topol
Journal:  N Engl J Med       Date:  1995-08-31       Impact factor: 91.245

10.  Variation in the use of cardiac procedures after acute myocardial infarction.

Authors:  E Guadagnoli; P J Hauptman; J Z Ayanian; C L Pashos; B J McNeil; P D Cleary
Journal:  N Engl J Med       Date:  1995-08-31       Impact factor: 91.245

View more
  2 in total

1.  Reason over reflex in acute ischemic syndromes: the case for a rational application of invasive procedures:.

Authors:  K A Brown
Journal:  J Nucl Cardiol       Date:  2000 Jul-Aug       Impact factor: 5.952

2.  Evaluation of the unstable angina patient in 2005: is there still a role for noninvasive risk stratification?

Authors:  Kenneth A Brown
Journal:  J Nucl Cardiol       Date:  2005 Jan-Feb       Impact factor: 5.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.